BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35982904)

  • 1. Tsp2 Facilitates Tumor-associated Fibroblasts Formation and Promotes Tumor Progression in Retroperitoneal Liposarcoma.
    Xu C; Yan L; Guan X; Wang Z; Wu J; Lv A; Liu D; Liu F; Dong B; Zhao M; Jia L; Tian X; Hao C
    Int J Biol Sci; 2022; 18(13):5038-5055. PubMed ID: 35982904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of TYMS as a promoting factor of retroperitoneal liposarcoma progression: Bioinformatics analysis and biological evidence.
    Zhang S; Yan L; Cui C; Wang Z; Wu J; Zhao M; Dong B; Guan X; Tian X; Hao C
    Oncol Rep; 2020 Aug; 44(2):565-576. PubMed ID: 32627015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and evaluation of retroperitoneal liposarcoma patient-derived xenograft models: an ideal model for preclinical study.
    Xu C; Yan L; An Q; Zhang S; Guan X; Wang Z; Lv A; Liu D; Liu F; Dong B; Zhao M; Tian X; Hao C
    Int J Med Sci; 2022; 19(8):1241-1253. PubMed ID: 35928724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and function of Siglec-15 in RLPS and its correlation with PD-L1: Bioinformatics Analysis and Clinicopathological Evidence.
    Cui L; Tian X; Yan L; Guan X; Dong B; Zhao M; Lv A; Liu D; Wu J; Hao C
    Int J Med Sci; 2022; 19(13):1977-1988. PubMed ID: 36438917
    [No Abstract]   [Full Text] [Related]  

  • 5. Downregulation of RRM2 Attenuates Retroperitoneal Liposarcoma Progression via the Akt/mTOR/4EBP1 Pathway: Clinical, Biological, and Therapeutic Significance.
    Zhang S; Yan L; Cui C; Wang Z; Wu J; Lv A; Zhao M; Dong B; Zhang W; Guan X; Tian X; Hao C
    Onco Targets Ther; 2020; 13():6523-6537. PubMed ID: 32753891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive immune characterization and T-cell receptor repertoire heterogeneity of retroperitoneal liposarcoma.
    Yan L; Wang Z; Cui C; Guan X; Dong B; Zhao M; Wu J; Tian X; Hao C
    Cancer Sci; 2019 Oct; 110(10):3038-3048. PubMed ID: 31385405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated fibroblasts promote the proliferation and decrease the doxorubicin sensitivity of liposarcoma cells.
    Harati K; Daigeler A; Hirsch T; Jacobsen F; Behr B; Wallner C; Lehnhardt M; Becerikli M
    Int J Mol Med; 2016 Jun; 37(6):1535-41. PubMed ID: 27082154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG).
    Nessim C; Raut CP; Callegaro D; Barretta F; Miceli R; Fairweather M; Blay JY; Strauss D; Rutkowski P; Ahuja N; Gonzalez R; Grignani G; Quagliuolo V; Stoeckle E; Lahat G; De Paoli A; Pillarisetty VG; Canter RJ; Mullen JT; Pennacchioli E; van Houdt W; Swallow CJ; Schrage Y; Cardona K; Fiore M; Gronchi A; Bagaria SP
    Ann Surg Oncol; 2021 Nov; 28(12):7854-7863. PubMed ID: 33907921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery.
    Keung EZ; Hornick JL; Bertagnolli MM; Baldini EH; Raut CP
    J Am Coll Surg; 2014 Feb; 218(2):206-17. PubMed ID: 24315890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNM classification of malignant tumors: Eighth edition for retroperitoneal liposarcoma. Ways to improve.
    Nered SN; Volkov AY; Kozlov NA; Stilidi IS; Arhiri PP
    Asia Pac J Clin Oncol; 2023 Oct; 19(5):e267-e272. PubMed ID: 36385584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma.
    Singer S; Antonescu CR; Riedel E; Brennan MF
    Ann Surg; 2003 Sep; 238(3):358-70; discussion 370-1. PubMed ID: 14501502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy for retroperitoneal liposarcoma: A report from the Transatlantic Retroperitoneal Sarcoma Working Group.
    Haas RLM; Bonvalot S; Miceli R; Strauss DC; Swallow CJ; Hohenberger P; van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Gladdy R; Jakob J; Szacht M; Fiore M; Chung PW; van Houdt WJ; Raut CP; Gronchi A
    Cancer; 2019 Apr; 125(8):1290-1300. PubMed ID: 30602058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dedifferentiated liposarcoma with inflammatory myofibroblastic tumor-like features: a clinicopathological analysis of five cases].
    Si HP; Wang Z; Fan QH; Zhang YF; Yang DQ; Zhang ZH; Gong QX
    Zhonghua Bing Li Xue Za Zhi; 2019 Apr; 48(4):282-287. PubMed ID: 30955263
    [No Abstract]   [Full Text] [Related]  

  • 14. Multi-omics joint analysis revealed the metabolic profile of retroperitoneal liposarcoma.
    Xie F; Niu Y; Lian L; Wang Y; Zhuang A; Yan G; Ren Y; Chen X; Xiao M; Li X; Xi Z; Zhang G; Qin D; Yang K; Zheng Z; Zhang Q; Xia X; Li P; Gu L; Wu T; Luo C; Lin SH; Li W
    Front Med; 2023 Dec; ():. PubMed ID: 38157196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of retroperitoneal liposarcoma extending into the inguinal canal and inguinoscrotal liposarcoma.
    Rhu J; Cho CW; Lee KW; Park H; Park JB; Choi YL; Kim SJ
    Can J Surg; 2017 Dec; 60(6):399-407. PubMed ID: 28930047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of prognostic factors for liposarcoma].
    Zhang Q; Li JM; Liu JL; Wei YZ
    Zhonghua Zhong Liu Za Zhi; 2019 Dec; 41(12):943-948. PubMed ID: 31874553
    [No Abstract]   [Full Text] [Related]  

  • 17. [Advances in the etiology of retroperitoneal liposarcoma].
    Yuan ZQ; Liu YB
    Zhonghua Wai Ke Za Zhi; 2024 May; 62(5):472-476. PubMed ID: 38548619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of intraoperative radiation therapy and high cumulative radiation doses in retroperitoneal soft tissue sarcoma.
    Willis F; Schimmack S; Uhl M; Haefner MF; Mechtersheimer G; Hinz U; Schmidt T; Debus J; Fröhling S; Schneider M
    Eur J Surg Oncol; 2020 May; 46(5):905-913. PubMed ID: 31892479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Retroperitoneal dedifferentiated liposarcoma with rhabdomyoblastic differentiation: a clinicopathological analysis].
    Liu L; Wang LH; Ren YB; Rao XS; Yang SM
    Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):94-98. PubMed ID: 29429159
    [No Abstract]   [Full Text] [Related]  

  • 20. Update on genomic and molecular landscapes of well-differentiated liposarcoma and dedifferentiated liposarcoma.
    Lu J; Wood D; Ingley E; Koks S; Wong D
    Mol Biol Rep; 2021 Apr; 48(4):3637-3647. PubMed ID: 33893924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.